In this study, the results displayed that the ALT level was gradually decreased during rhGH therapy, which suggest that GH probably has potential values in prevention and treatment of NAFLD in short children and adolescents with the low GH state. Here, GH1 is linked to metabolic dysfunction-associated steatotic liver disease.